Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Symptom-directed neurologic therapies
3 evidence topics · 1 source
SL1009 (sodium dichloroacetate)
Pyruvate dehydrogenase complex deficiency
- Manufacturer
- Saol Therapeutics
- Regulatory submission
- NDA resubmitted June 2026
- Launch
- Not announced
- Last updated